Navigation Links
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Date:9/12/2013

inhibitor in treatment-naive patients. PIs are often selected as part of a first-line regimen for treatment-naive patients, so these data provide important information regarding dolutegravir as a treatment choice for these patients."

The most commonly (>10%) reported adverse events in either study arm were diarrheoa (dolutegravir 17% vs boosted darunavir 29%), nausea (16% vs 18%), and headache (15% vs 10%). Study participants on the dolutegravir regimen had significantly fewer Grade 2 or higher abnormalities in fasting LDL-cholesterol (dolutegravir 2% vs darunavir 7%, [p<0.001]). Serious adverse events (SAEs) were reported among 11% and 5% of patients receiving a regimen containing dolutegravir (N=242) or boosted darunavir (N=242), respectively, with one SAE attributed by the investigator to dolutegravir treatment.

FLAMINGO (a Phase IIIb/IV study) follows four Phase III studies, which examined the efficacy and safety of dolutegravir. It is the third study in treatment-naive adults with HIV-1. Data from SPRING-2 (ING113086), SINGLE (ING114467) and VIKING-3 (ING112574) were announced in 2012, and data from SAILING (ING111762) were announced in 2013: these four studies formed the basis of the registration package leading to the U.S. Food and Drug Administration (FDA) approval of Tivicay® on 12 August 2013. Please refer to the full U.S. prescribing and patient information at:
https://www.viivhealthcare.com/media/58599/us_tivicay.pdf  

Important Information About Tivicay® (dolutegravir)
Indication and Usage: TIVICAY is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and children aged 12 years and older and weighing at least 40 kg. The following should be considered prior to initiating TIVIC
'/>"/>

SOURCE ViiV Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... NEW YORK , July 6, 2015 ... , Chairman, will present live at VirtualInvestorConferences.com on July ... AM EDT LINK: http://tinyurl.com/e-qure-presentation ... investors are invited to ask the company questions in ... as the association,s "virtual trade booth." If attendees are ...
(Date:7/6/2015)... 2015 Array BioPharma,s (NASDAQ:   ARRY) ... weekend at the 2015 ESMO World Congress of ... meeting, data were shared from a Phase 1b ... Phase 2 expansion of that trial testing the ... with or without the addition of alpelisib (BYL719) ...
(Date:7/6/2015)... and SOUTH SAN FRANCISCO, Calif. ... (NYSE: AGN ), a leading global pharmaceutical company, ... developing novel treatments for dry eye disease, today announced ... Allergan will acquire Oculeve in an all-cash transaction.  Under ... for a $125 million upfront payment and commercialization milestone ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4
... The U.S. Food and Drug Administration today approved ... and Zyprexa Zydus (olanzapine orally disintegrating tablets) to ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Schizophrenia is a ... percent of Americans have this illness. Symptoms people ...
... Oct. 24, 2011 Masimo (NASDAQ: ... global manufacturer of electronic medical devices and patient ... licensing agreement and the launch of Masimo rainbow® ... of modular patient monitors. The agreement allows Biolight ...
Cached Medicine Technology:FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 2Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 4Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 5Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 6
(Date:7/6/2015)... ... July 06, 2015 , ... “ TapGlance ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this interior design app helps users visualize what rooms will look ...
(Date:7/6/2015)... ... ... Shortly after opening her second practice in Signal Hill, Dr. Sue Lim ... lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, DC a ... Lim suffered with back pain herself throughout high school. Unaware of the benefits ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
(Date:7/6/2015)... ... 2015 , ... Longevity, the highest regarded provider of early ... Care to offer on-site health screenings. These ultrasound screenings detect early signs of ... accurate and run about an hour long with same day results. , Early ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Carlson & Associates has once again teamed up with Family Emergency Shelter Coalition ... to move toward self-sufficiency. FESCO was created especially to provide emergency services and ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3
... The new cancer medication sorafenib looks promising. Sorafenib is ... appears to be effective against cancer stem cells in ... Herr, Head of the Department of Molecular Oncosurgery, a ... Hospital, (Managing Director: Professor Dr. Markus W. Bchler) in ...
... reason why depression and other stress-related psychiatric disorders are ... signaling systems in animal brains, neuroscience researchers found that ... important stress hormone and less able to adapt to ... evidence for sex differences in how neurotransmitter receptors traffic ...
... EMBL captured this snapshot of the beginnings of an organ ... world around them. This image may bring to mind a ... abstract paintings, but the artisan behind it is actually Mother ... Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Using an electron ...
... ... , ... (PRWEB) June 15, 2010 -- ZocDoc, the website to find doctors and ... move was chosen by thousands of users, who were asked which American city needed ...
... BMI of ... it was named one of the “Best Places to Work” in San Antonio by the ... (companies with 1-50 employees), earning this prestigious accolade just 18 months after the company was ... (PRWEB) June 15, ...
... , ... agriculture practices ensure animal safety, affordable food prices , ... (PRWEB) June 15, 2010 -- The United ... on the group’s new Web pages, which feature, among other things, farmers utilizing modern ...
Cached Medicine News:Health News:New combination effective against pancreatic cancer 2Health News:Higher anxiety, depression among women may have basis in cell signals 2Health News:Chicago Votes for Improved Healthcare with ZocDoc 2Health News:San Antonio Business Journal Names BMI of Texas One of the Best Places to Work in San Antonio 2Health News:San Antonio Business Journal Names BMI of Texas One of the Best Places to Work in San Antonio 3Health News:United Soybean Board New Site Features Farmers', Ranchers' Animal Care 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: